Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction

Part of paid clinical trials in Norfolk, Virginia.

Sponsor
Old Dominion University
Study ID
NCT07644806
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Heart Failure With Reduced Ejection Fraction (HFrEF)

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Extra-virgin olive oil — OTHER
    At least 4 tablespoons of extra-virgin olive oil per day

Study Details

The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.

Key Dates

Start date
Jul 1, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2027
Completion
Mar 31, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Extra-virgin olive oil
  • No Intervention: Standard of care
    Cardiac rehabilitation as part of standard of care

Primary Outcome Measure

Change in 24-hour dietary recall monounsaturated fatty acids (MUFA) [ Time Frame: At baseline, and 12-week ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Strelitz Diabetes Center (Williams Hall)NorfolkVirginia23510
Salvatore Carbone, PhD, RDN
[email protected]
7574467149
Saiful Anuar Bin Singar, PhD
[email protected]
757-446-7149

Find similar trials in Norfolk, VA

By research site
Strelitz Diabetes Center (Williams Hall)· Norfolk, VA

Related Studies